{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:53:49Z","timestamp":1777679629933,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"DOI":"10.7759\/cureus.105505","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:11:27Z","timestamp":1773936687000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Pazopanib-Associated Interstitial Lung Disease in a Patient With Ulcerative Colitis and Metastatic Sarcoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Charles L","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Kokkosis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geremy","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Mashriqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.11087","article-title":"Associations of socioeconomic status, public vs private insurance, and race\/ethnicity with metastatic sarcoma at diagnosis","volume":"3","author":"Diessner BJ","year":"2020","unstructured":"Diessner BJ, Weigel BJ, Murugan P, Zhang L, Poynter JN, Spector LG. Associations of socioeconomic status, public vs private insurance, and race\/ethnicity with metastatic sarcoma at diagnosis. JAMA Netw Open. 2020, 3:e2011087. 10.1001\/jamanetworkopen.2020.11087","journal-title":"JAMA Netw Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf WTA","year":"2012","unstructured":"van der Graaf WTA, Blay JY, Chawla SP, et al.. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2012, 379:1879-1886. 10.1016\/S0140-6736(12)60651-5","journal-title":"The Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14848","article-title":"Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real\u2011world data","volume":"29","author":"S\u00f6ylemez CM","year":"2025","unstructured":"S\u00f6ylemez CM, G\u00fcrsoy P, \u015eanli UA. Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real\u2011world data. Oncol Lett. 2025, 29:102. 10.3892\/ol.2024.14848","journal-title":"Oncol Lett"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000439427","article-title":"Successful treatment with pazopanib for multiple lung metastases of inguinal epithelioid sarcoma: a case report","volume":"8","author":"Irimura S","year":"2015","unstructured":"Irimura S, Nishimoto K, Kikuta K, et al.. Successful treatment with pazopanib for multiple lung metastases of inguinal epithelioid sarcoma: a case report. Case Rep Oncol. 2015, 8:378-84. 10.1159\/000439427","journal-title":"Case Rep Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254866","article-title":"Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: a case series analysis","volume":"16","author":"Aiba H","year":"2021","unstructured":"Aiba H, Kimura H, Yamada S, et al.. Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: a case series analysis. PLoS One. 2021, 16:e0254866. 10.1371\/journal.pone.0254866","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg CN","year":"2010","unstructured":"Sternberg CN, Davis ID, Mardiak J, et al.. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol. 2010, 28:1061-8. 10.1200\/JCO.2009.23.9764","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7380","article-title":"Interstitial Lung Disease Induced by Pazopanib Treatment","volume":"56","author":"Ide S","year":"2017","unstructured":"Ide S, Sakamoto N, Hara S, et al.. Interstitial Lung Disease Induced by Pazopanib Treatment. Intern Med. 2017, 56:79-83. 10.2169\/internalmedicine.56.7380","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235177","article-title":"Pazopanib-associated interstitial lung disease in a patient with renal cell carcinoma","volume":"13","author":"Harada Y","year":"2020","unstructured":"Harada Y, Kakimoto S, Shimizu T. Pazopanib-associated interstitial lung disease in a patient with renal cell carcinoma. BMJ Case Rep. 2020, 13:10.1136\/bcr-2020-235177","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0438-0","article-title":"Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan","volume":"18","author":"Horiuchi-Yamamoto Y","year":"2013","unstructured":"Horiuchi-Yamamoto Y, Gemma A, Taniguchi H, et al.. Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan. Int J Clin Oncol. 2013, 18:743-9. 10.1007\/s10147-012-0438-0","journal-title":"Int J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen S","year":"2010","unstructured":"Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med. 2010, 42:97-114. 10.3109\/07853890903559724","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S204730","article-title":"Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?","volume":"13","author":"Huang Y","year":"2019","unstructured":"Huang Y, Lin W, Chen Z, Wang Y, Huang Y, Tu S. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?. Drug Des Devel Ther. 2019, 13:2111-25. 10.2147\/DDDT.S204730","journal-title":"Drug Des Devel Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-86-1-81","article-title":"Pulmonary effects of radiation therapy","volume":"86","author":"Gross NJ","year":"1977","unstructured":"Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med. 1977, 86:81-92. 10.7326\/0003-4819-86-1-81","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.7.2613","article-title":"Radiation induced lung injury: prediction, assessment and management","volume":"16","author":"Giridhar P","year":"2015","unstructured":"Giridhar P, Mallick S, Rath GK, Julka PK. Radiation induced lung injury: prediction, assessment and management. Asian Pac J Cancer Prev. 2015, 16:2613-7. 10.7314\/apjcp.2015.16.7.2613","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-025-00338-7","article-title":"Drug-induced pulmonary toxicity in the era of immunotherapy and biologics: a narrative review of mechanism, diagnosis, and management","author":"Poveda JJ","year":"2026","unstructured":"Poveda JJ, Tamayo MH, Huizi JJ, Sellares J, Hern\u00e1ndez-Gonz\u00e1lez F. Drug-induced pulmonary toxicity in the era of immunotherapy and biologics: a narrative review of mechanism, diagnosis, and management. Pulm Ther. 2026, 10.1007\/s41030-025-00338-7","journal-title":"Pulm Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1648-2","article-title":"Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials","volume":"68","author":"Binder D","year":"2011","unstructured":"Binder D, H\u00fcbner RH, Temmesfeld-Wollbr\u00fcck B, Schlattmann P. Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials. Cancer Chemother Pharmacol. 2011, 68:1575-83. 10.1007\/s00280-011-1648-2","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/333411-acute-pazopanib-associated-interstitial-lung-disease-in-a-patient-with-ulcerative-colitis-and-metastatic-sarcoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:11:28Z","timestamp":1773936688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/333411-acute-pazopanib-associated-interstitial-lung-disease-in-a-patient-with-ulcerative-colitis-and-metastatic-sarcoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.105505","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}